Everest Organics board to meet on May 29 to consider FY26 results

1 min read     Updated on 21 May 2026, 01:45 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Everest Organics Limited will hold a board meeting on May 29, 2026, to approve audited standalone financial results for the quarter and year ended March 31, 2026. The board will also review the statutory auditor's draft report. The trading window remains closed until 48 hours post-results declaration.

powered bylight_fuzz_icon
40896894

*this image is generated using AI for illustrative purposes only.

Everest Organics Limited has informed the stock exchanges that its board of directors will meet on Friday, May 29, 2026. The meeting has been convened pursuant to Regulations 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for the Meeting

The primary agenda for the upcoming board meeting includes the consideration and approval of the audited standalone financial results of the company for the quarter and year ended March 31, 2026. Additionally, the directors will take note of the draft report of the statutory auditors for the financial year ending March 31, 2026.

Trading Window Closure

In accordance with regulatory requirements, the company had previously intimated that the trading window closure period commenced on April 01, 2026. This window shall remain closed until 48 hours after the declaration of the audited standalone financial results for the quarter and year ended March 31, 2026.

Key Meeting Details

Detail Information
Meeting Date May 29, 2026
Purpose Consider Audited Financial Results for FY26
Financial Year End March 31, 2026
Trading Window Closure From April 01, 2026

The intimation regarding this board meeting is available on the company's official website and the website of the stock exchange where its shares are listed.

Historical Stock Returns for Everest Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-3.87%-3.68%-11.18%-42.57%-42.14%-25.49%

How does Everest Organics Limited's revenue and profit growth for FY26 compare to its peers in the pharmaceutical and specialty chemicals sector?

Will the board consider announcing a dividend or any capital allocation strategy alongside the FY26 financial results approval?

Are there any pending regulatory inspections or compliance issues that could impact the auditor's report and overall financial health of the company?

Everest Organics Limited Submits Q4FY26 Dematerialization Compliance Certificate to BSE

1 min read     Updated on 10 Apr 2026, 08:06 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Everest Organics Limited filed its Q4FY26 compliance certificate with BSE on April 10, 2026, under SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by Venture Capital and Corporate Investments Private Limited, confirms proper dematerialization compliance including timely processing of securities and updating of depositories NSDL and CDSL as registered owners within the mandated 15-day period.

powered bylight_fuzz_icon
37377391

*this image is generated using AI for illustrative purposes only.

Everest organics Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated April 10, 2026, covers the quarter ended March 31, 2026.

Regulatory Compliance Certificate

The company submitted the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This quarterly filing confirms the company's adherence to dematerialization compliance requirements for its listed securities.

Parameter: Details
Scrip Code: 524790
Quarter Ended: March 31, 2026
Filing Date: April 10, 2026
Regulation: SEBI (Depositories and Participants) Regulations, 2018

Certificate Details and Verification

Venture Capital and Corporate Investments Private Limited, serving as the company's Registrar to an Issue and Share Transfer Agent, issued the compliance certificate on April 06, 2026. The certificate confirms that securities received for dematerialization have been properly processed according to regulatory standards.

Key compliance confirmations include:

  • Securities received for dematerialization were mutilated and cancelled after due verification
  • National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) updated as registered owners
  • Processing completed within the mandated 15-day period from receipt of valid DRF and share certificates
  • Details of securities furnished to relevant stock exchanges

Corporate Information

Everest Organics Limited operates as an ISO 9001:2015 and WHO GMP certified company. The company maintains its corporate office at Dwaraka Heights, Madhapur, Hitech City, Hyderabad, with its registered office and factory located at Aroor Village, Sadasivpet Mandal, Sangareddy District, Telangana.

Company Details: Information
CIN: L24230TG1993PLC015426
Certifications: ISO 9001:2015 & WHO GMP
Corporate Office: Hyderabad, Telangana
Factory Location: Sangareddy District, Telangana

The certificate has been made available on the company's website at everestorganicsltd.com, ensuring transparency and accessibility for stakeholders. Company Secretary and Compliance Officer Shweta Singh signed the submission, confirming the company's commitment to regulatory compliance and corporate governance standards.

Historical Stock Returns for Everest Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-3.87%-3.68%-11.18%-42.57%-42.14%-25.49%

Will Everest Organics' ISO 9001:2015 and WHO GMP certifications help the company secure new international contracts in the pharmaceutical sector?

How might the company's consistent regulatory compliance impact its credit rating and access to capital markets in 2026?

Could Everest Organics be positioning itself as an acquisition target given its strong compliance record and strategic Hyderabad location?

More News on Everest Organics

1 Year Returns:-42.14%